AI identifies developmental defects and drug mechanisms in embryos

Müller, P

doi:10.1038/s41592-023-01872-5

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

AI identifies developmental defects and drug mechanisms in embryos

MPS-Authors

/persons/resource/persons206891

Müller, P
Müller Group, Friedrich Miescher Laboratory, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Müller, P. (2023). AI identifies developmental defects and drug mechanisms in embryos. Nature Methods, 20(6), 793-794. doi:10.1038/s41592-023-01872-5.

Cite as: https://hdl.handle.net/21.11116/0000-000F-7703-8

Abstract

We developed EmbryoNet, a deep learning tool that can automatically identify and classify developmental defects caused by perturbations of signaling pathways in vertebrate embryos. The tool could help to elucidate the mechanisms of action of pharmaceuticals, potentially transforming the drug discovery process.